A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial ...
Dec 7, 2014
0
1
Neurodevelopmental disorders such as Down syndrome and autism-spectrum disorder can have profound, lifelong effects on learning and memory, but relatively little is known about the molecular pathways affected by these diseases. ...
Oct 9, 2014
0
0
A new study from Karolinska Institutet in Sweden shows that a part of the nervous system, the parasympathetic nervous system, is formed in a way that is different from what researchers previously believed. In this study, ...
Jun 12, 2014
8
0
During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature into luminal or basal cells.
May 2, 2014
0
0
Your immune system's B cells can respond to an amazing number of pathogens—viruses, bacteria, etc.—without ever having encountered them. That's because, as they develop, your B cells reshuffle their antibody-producing ...
Nov 27, 2013
1
0
A program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor, scientists at The University of Texas MD Anderson ...
Aug 8, 2013
0
0
Blind mice have been able to see once more in a laboratory exploit that marks a further boost for the fast-moving field of retinal therapy, according to a study published on Sunday.
Jul 22, 2013
0
0
(Medical Xpress)—Cells from one's own blood could be converted into a treatment for autoimmune diseases, like rheumatoid arthritis and Crohn's disease, based on the discovery of a Purdue University researcher.
Jul 18, 2013
0
0
(Medical Xpress)—The development of new drugs for improving treatment of Alzheimer's and Parkinson's disease is a step closer after recent research into how stem cells migrate and form circuits in the brain.
Jul 18, 2013
0
0
Scientists have successfully targeted a malfunctioning immune system enzyme to kill diseased cells from patients with myelodysplastic syndrome (MDS)—a blood disorder and precursor to leukemia.
Jul 8, 2013
0
0
